NCT02155946View on ClinicalTrials.gov

Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment

NACompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

December 1, 2014

Primary Completion Date

February 28, 2021

Study Completion Date

March 31, 2021

Conditions
Mild Cognitive ImpairmentAlzheimer's Disease
Interventions
DEVICE

Transcranial direct current stimulation (tDCS) Soterix Medical Inc. tDCS unit

Active brain stimulation

DEVICE

Transcranial direct current stimulation (tDCS) Soterix Medical Inc. tDCS unit

Sham (placebo)

Trial Locations (1)

48105

VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT02155946 - Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment | Biotech Hunter | Biotech Hunter